Suchergebnisse - "McGeer, Allison J"

PubPharm (6)

1

Sensitivity to Neutralizing Antibodies and Resistance to Type I Interferons in SARS-CoV-2 R.1 Lineage Variants, Canada

enthalten in: Emerging infectious diseases | 2023

von Jacob, R. | Zhang, A. | Ajoge, H. | +22

2

Immunogenicity of convalescent and vaccinated sera against clinical isolates of ancestral SARS-CoV-2, Beta, Delta, and Omicron variants

enthalten in: Med (New York, N.Y.) | 2022

von Banerjee, A. | Lew, J. | Kroeker, A. | +20

3

Persistence of T Cell and Antibody Responses to SARS-CoV-2 Up to 9 Months after Symptom Onset

enthalten in: Journal of immunology (Baltimore, Md. : 1950) | 2022

von Law, J. | Girard, M. | Chao, G. | +13

4

Evaluation of the SARS-CoV-2 Antibody Response to the BNT162b2 Vaccine in Patients Undergoing Hemodialysis

enthalten in: JAMA network open | 2021

von Yau, K. | Abe, K. | Naimark, D. | +18

ErratumIn: JAMA Netw Open. 2022 Feb 1;5(2):e221422. - PMID 35157065

5

Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients

enthalten in: Science immunology | 2020

von Isho, B. | Abe, K. | Zuo, M. | +33

6

A simple protein-based surrogate neutralization assay for SARS-CoV-2

enthalten in: JCI insight | 2020

von Abe, K. | Li, Z. | Samson, R. | +20

1
[1]